EMPLOYMENT AGREEMENT
Exhibit 99.2
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of June 26, 2006 by and between
Critical Therapeutics, Inc., a Delaware corporation with its principal place of business at 00
Xxxxxxxx Xxxxxx, Xxxxxxxxx, XX 00000 (the “Company”), and Xxxxxxx X. Xxxxx, residing at 000
Xxxxxxx Xxxxxx, Xxxxxxx, XX 00000 (the “Executive”).
WHEREAS, the Company desires to employ the Executive, and the Executive desires to be employed by
the Company.
In consideration of the mutual covenants and promises contained herein, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto,
the parties agree as follows:
1. Term of Employment. The Company hereby agrees to employ the Executive, and the
Executive hereby accepts employment with the Company, upon the terms set forth in this Agreement,
for the period commencing on June 26, 2006 (the “Commencement Date”) and ending on December 31,
2007 (the “Initial Term”) unless renewed or sooner terminated in accordance with the provisions of
this Section 1 or Section 4 respectively. Upon each subsequent anniversary of the Commencement
Date, the term of this Agreement shall automatically extend for an additional year (such period,
including the Initial Term and as it may be extended, the “Employment Period”) unless (i) either
the Company or the Executive gives at least ninety (90) days notice of non-renewal prior to such
anniversary or (ii) the Agreement is terminated in accordance with the provisions of Section 4.
2. Title; Capacity. The Executive shall serve as Vice President of Finance, Chief
Accounting Officer and Treasurer or in such other position as the Company or its Board of Directors
(the “Board”) may determine from time to time. The Executive shall be based at the Company’s
office in Lexington, MA. The Executive shall be subject to the supervision of, and shall have such
authority as is delegated to him by the President of the Company or his designee.
The Executive hereby accepts such employment and agrees to undertake the duties and
responsibilities inherent in such position and such other duties and responsibilities as the Board
or its designee shall from time to time reasonably assign to him. The Executive agrees to devote
his entire business time, attention and energies to the business and interests of the Company
during the Employment Period; provided, however, that the Executive may serve as a
consultant or a member of an advisory board or a board of directors with the prior consent of the
Board. The Executive agrees to abide by any rules, regulations, instructions, personnel practices
and policies of the Company that are applicable to him and any changes therein that may be adopted
from time to time by the Company.
3. Compensation and Benefits.
3.1. Salary. The Company shall pay the Executive a base salary in semi-monthly
installments at an annualized rate of $185,000 (equal to $7,708.33) per semi-monthly pay period),
less lawful deductions. Such salary shall be subject to adjustment thereafter as
determined by the Board.
3.2. Annual Target Cash Bonus. The Executive shall be eligible to receive an annual
target cash bonus of up to thirty (30) percent of his then annual base salary (“Target Cash
Bonus”). The Compensation Committee of the Board shall determine the amount of the actual award,
if any, based on overall corporate performance and individual performance. Actual awards may be
greater than or less than the Executive’s Target Cash Bonus, depending in part upon the extent to
which actual performance exceeds or falls below the performance goals. Any bonus shall be paid in
a single lump sum, subject to lawful deductions, at such time as bonuses are regularly paid to
senior executives of the Company. Each cash bonus award that may become payable shall be paid
solely from the general assets of the Company.
3.3. Annual Equity Awards. The Executive shall be eligible to receive annual equity
awards. The Compensation Committee of the Board shall determine the amount of the actual equity
award, if any, based on overall corporate performance and individual performance.
3.4. Fringe Benefits. The Executive shall be entitled to participate in all bonus
and benefit programs that the Company establishes and makes available to its employees or
executives, if any, to the extent that the Executive’s position, tenure, salary, age, health and
other qualifications make him eligible to participate; provided, however, the
Executive shall not be eligible to participate in the Company’s Cash Bonus Program for Employees
(Other than Executive Officers). The Executive shall be entitled to three (3) weeks of paid
vacation per year, accrued at a rate of 1.25 days per month until the Executive has completed four
(4) years of service at which time vacation shall accrue at 1.67 days per month (four (4) weeks per
year), and, if requested in writing by the President, such vacation time shall be taken at such
times as may be approved by the President or his designee.
3.5. Reimbursement of Expenses. The Company shall reimburse the Executive for all
reasonable travel, entertainment and other expenses incurred or paid by the Executive in connection
with, or related to, the performance of his duties, responsibilities or services under this
Agreement, upon presentation by the Executive of documentation, expense statements, vouchers and/or
such other supporting information as the Company may request, provided, however,
that the amount available for such travel, entertainment and other expenses may be fixed in advance
by the Board.
4. Employment Termination. The employment of the Executive by the Company pursuant to
this Agreement shall terminate upon the occurrence of any of the following:
4.1. Expiration of the Employment Period in accordance with Section 1;
4.2. At the election of the Company, for Cause (as defined in Section 21), immediately upon
written notice by the Company to the Executive;
4.3. At the election of the Executive, for Good Reason (as defined in Section 21), immediately
upon written notice by the Executive to the Company;
- 2 -
4.4. At the election of the Company without Cause during a Change of Control Period (as
defined in Section 21) or at the election of the Executive for Good Reason during a Change of
Control Period;
4.5. Thirty (30) days after the death or disability (as defined in Section 21) of the
Executive;
4.6. At the election of the Executive by providing written notice to the Company; and
4.7. At the election of the Company, without Cause, by providing written notice to the
Executive.
5. Effect of Termination.
5.1. Termination for Cause. In the event the Executive’s employment is terminated for
Cause pursuant to Section 4.2, the Company shall pay to the Executive the compensation and benefits
otherwise payable to him under Section 3 through the last day of his actual employment by the
Company.
5.2. Termination at the Election of the Executive. In the event the Executive elects
to terminate his employment pursuant to Section 4.6, the Company shall pay the Executive the
compensation and benefits otherwise payable to him under Section 3 through the last day of his
actual employment by the Company. If the Executive provides ninety (90) days prior written notice,
the Executive shall receive in accordance with the Company’s regular payroll practices, a lump sum
payment in an amount equal to a pro rata payment (as defined in Section 21) of the annual cash
bonus, if any, paid to the Executive in the year prior to his resignation, subject to the
Executive’s execution of a severance agreement and release drafted by and satisfactory to counsel
for the Company. No other benefits are payable upon the Executive’s voluntary resignation unless
for Good Reason.
5.3. Termination for Death or Disability. If the Executive’s employment is terminated
by death or because of disability pursuant to Section 4.5, the Company shall pay, in accordance
with the Company’s regular payroll practices, to the estate of the Executive or to the Executive,
as the case may be, the compensation that would otherwise be payable to the Executive up to the end
of the month in which the termination of his employment because of death or disability occurs. In
addition, if the Executive’s employment terminates by death or because of a disability, all of his
outstanding unvested stock options and restricted stock shall become fully vested. If the
Executive’s employment terminates as a result of his death, the Executive’s estate shall also
receive an amount equal to a pro rata payment of the annual cash bonus, if any, paid to the
Executive in the year prior to his death, subject to the Executive’s estate’s execution of a
release drafted by and satisfactory to counsel for the Company.
5.4. Termination Without Cause or for Good Reason and not during a Change in Control
Period. If the Executive’s employment is terminated without Cause pursuant to
- 3 -
Section 4.7, or for Good Reason pursuant to Section 4.3 and such termination does not occur
during a Change of Control Period, the Company shall:
| (i) | pay the Executive, in accordance with the Company’s regular payroll practices, a lump sum payment equal to one (1) times his annualized base salary, less lawful deductions; | ||
| (ii) | pay the Executive on a monthly basis an amount equal to (a) eighty (80) percent of the Executive’s monthly health and dental COBRA premiums for the Executive and his dependents, if any, if the Executive properly elects to continue health and dental insurance under COBRA and (b) one hundred (100) percent of the cost of the monthly premiums paid by the Company for life insurance and disability insurance for the Executive in the month preceding the Executive’s termination of employment, such payments under subsections (a) and (b) to continue until the earlier of twelve (12) months after the termination of the Executive’s employment or until the last day of the first month that the Executive is eligible for other employer-sponsored health coverage; | ||
| (iii) | pay the Executive, in accordance with the Company’s regular payroll practices, a lump sum payment in an amount equal to a pro rata payment of the Target Cash Bonus for which he was eligible, less lawful deductions; | ||
| (iv) | accelerate vesting of fifty (50) percent of all of the Executive’s outstanding unvested stock options and restricted stock; and | ||
| (v) | provide the Executive with up to three (3) months of outplacement services as arranged for by the Company, |
all such payments subject to the Executive’s execution of a severance agreement and release
drafted by and satisfactory to counsel for the Company.
5.5. Termination Without Cause or for Good Reason during a Change in Control Period.
If the Executive’s employment is terminated without Cause pursuant to Section 4.7, or for Good
Reason pursuant to Section 4.3 and such termination occurs during a Change of Control Period, the
Company shall:
| (i) | pay the Executive, in accordance with the Company’s regular payroll practices, a lump sum payment equal to one (1) times his annualized base salary, less lawful deductions; | ||
| (ii) | pay the Executive, in accordance with the Company’s regular payroll practices, on a monthly basis an amount equal to (a) eighty (80) percent of the Executive’s monthly health and dental COBRA premiums for the Executive and his dependents, if any, if the Executive properly elects to continue health and dental insurance under COBRA and (b) one hundred (100) percent of the cost of the monthly premiums paid by the Company for life insurance and disability |
- 4 -
| insurance for the Executive in the month preceding the Executive’s termination of employment, such payments under subsections (a) and (b) to continue until the earlier of twelve (12) months after the termination of the Executive’s employment or until the last day of the first month that the Executive is eligible for other employer-sponsored health coverage; | |||
| (iii) | pay the Executive, in accordance with the Company’s regular payroll practices, a lump sum payment in an amount equal to a pro rata payment of the Target Cash Bonus for which he was eligible, less lawful deductions; | ||
| (iv) | accelerate vesting of one hundred (100) percent of all of the Executive’s outstanding unvested stock options and restricted stock; and | ||
| (v) | provide the Executive with up to three (3) months of outplacement services as arranged for by the Company, |
all such payments subject to the Executive’s execution of a severance agreement and release
drafted by and satisfactory to counsel for the Company.
6. Vesting of Stock Upon a Change of Control. Fifty (50) percent of the Executive’s
outstanding unvested stock options and restricted stock will vest on a Change of Control (as
defined in Section 21).
7. Non-Compete.
(a) During the Employment Period and for a period of one (1) year after the termination or
expiration of the Executive’s employment for any reason or after a Change in Control, the Executive
will not directly or indirectly:
(i) as an individual proprietor, partner, stockholder, officer, employee, director, joint
venturer, investor, lender, or in any other capacity whatsoever (other than as the holder of not
more than one percent (1%) of the total outstanding stock of a publicly held company), engage in
the business of providing services or developing, producing, marketing or selling products within
the Geographic Territory (as defined below) which are competitive with endeavors at the Company
during the Employment Term or at the time of termination (“Company Endeavors”); provided, however,
the foregoing shall not prevent the Executive from the following: (X) after the six (6) months
immediately following termination of the Executive’s employment, working as employee or a
consultant to such a business if his position and scope of responsibilities at such business were
completely and entirely unrelated, directly or indirectly, to endeavors competitive with the
Company Endeavors; or (Y) after the six (6) months immediately following termination of
Executive’s employment, working for or on behalf of, or serving as a consultant or an advisor to, a
non-profit academic organization. As of the date of this Agreement, the term “Company Endeavors”
includes the following programs and/or targets: (i) 5-lipoxygenase (“5-LO”), (ii) 5-lipoxygenase
activating protein (“FLAP”), (iii) high mobility group protein B1 and its receptors (“HMGB1”), (iv)
the alpha-7 nicotinic receptor (“a-7”) in
- 5 -
inflammation, and (v) ethyl pyruvate (“CTI-01”). At termination, upon the Executive’s
request, the Company will provide an updated list of the specific Company Endeavors to the
Executive.
(ii) either alone or in association with others, recruit, solicit, induce, hire or engage as
an independent contractor or attempt to recruit, solicit, induce, hire or engage as an independent
contractor, any person who then is or was employed by the Company except for an individual whose
employment with the Company has been terminated (X) by the employee for any reason other than Good
Reason for a period of six (6) months or longer, (Y) by the Company for any reason, or (Z) by the
employee for Good Reason.
(iii) either alone or in association with others, solicit, divert or take away, or attempt to
solicit, divert or take away, the business or patronage of any of the clients, customers or
accounts, or prospective clients, customers or accounts, of the Company which were contacted,
solicited or served by the Executive while employed by the Company.
(b) The Executive agrees that, if requested by the Company in writing, he will give notice to
the Company of each new business activity he plans to undertake during the non-competition period,
at least ten (10) business days prior to beginning any such activity. The notice shall state the
name and address of the individual, corporation, association or other entity or organization
(“Entity”) for whom such activity is undertaken and the name of the Executive’s business
relationship or position with the entity. The Executive further agrees to provide the Company with
other pertinent information concerning such business activity as the Company may reasonably request
in order to determine the Executive’s continued compliance with his obligations under this
Agreement. The Executive agrees that, if requested by the Company in writing, he will provide a
copy of Section 7 and 8 of this Agreement to all persons and Entities with whom he seeks to be
hired or do business before accepting employment or engagement with any of them.
(c) If any restriction set forth in this Section 7 is found by any court of competent
jurisdiction to be unenforceable because it extends for too long a period of time or over too great
a range of activities or in too broad a geographic area, it shall be interpreted to extend only
over the maximum period of time, range of activities or geographic area as to which it may be
enforceable.
(d) For purposes of this Section, “Geographic Territory” shall mean any state or locality in
the United States. The parties agree and acknowledge that the geographic scope of this provision
is reasonable in light of the geographically broad scope of the Company’s business.
(e) The Executive acknowledges that the restrictions contained in this Section are necessary
for the protection of the business and goodwill of the Company and in light of, among other things,
the highly competitive market in which the Company operates. The Executive agrees that any breach
of this Section will cause the Company substantial and irrevocable damage and therefore, in the
event of any such breach, in addition to such other remedies which may be available, the Company
shall have the right to seek specific performance and injunctive
- 6 -
relief without posting a bond.
(f) If the Executive violates the provisions of this Section, he shall continue to be held by
the restrictions set forth in this Section, until a period equal to the period of restriction has
expired without any violation.
8. Proprietary Information and Developments.
8.1. Proprietary Information.
(a) The Executive agrees that all information and know-how, whether or not in writing, of a
private, secret or confidential nature concerning the Company’s business or financial affairs
(collectively, “Proprietary Information”) is and shall be the exclusive property of the Company.
By way of illustration, but not limitation, Proprietary Information may include inventions,
products, processes, methods, techniques, formulas, compositions, compounds, projects,
developments, plans, research data, clinical data, financial data, personnel data, computer
programs, and customer and supplier lists. Executive will not disclose any Proprietary Information
to others outside the Company or use the same for any unauthorized purposes without written
approval by an officer of the Company, either during or after his employment, unless and until such
Proprietary Information has become public knowledge without fault by the Executive.
(b) The Executive agrees that all files, letters, memoranda, reports, records, data, sketches,
drawings, laboratory notebooks, program listings, or other written, photographic, or other tangible
material containing Proprietary Information, whether created by the Executive or others, which
shall come into his custody or possession, shall be and are the exclusive property of the Company
to be used by the Executive only in the performance of his duties for the Company.
(c) The Executive agrees that his obligation not to disclose or use information, know-how and
records of the types set forth in paragraphs (a) and (b) above, also extends to such types of
information, know-how, records and tangible property of customers of the Company or suppliers to
the Company or other third parties who may have disclosed or entrusted the same to the Company or
to the Executive in the course of the Company’s business.
8.2. Developments.
(a) The Executive will make full and prompt disclosure to the Company of all inventions,
improvements, discoveries, methods, developments, software, and works of authorship, whether
patentable or not, which are created, made, conceived or reduced to practice by the Executive or
under his direction or jointly with others during his employment by the Company, whether or not
during normal working hours or on the premises of the Company (all of which are collectively
referred to in this Agreement as “Developments”).
(b) The Executive agrees to assign and does hereby assign to the Company (or any person or
entity designated by the Company) all his right, title and interest in and to all
- 7 -
Developments and all related patents, patent applications, copyrights and copyright
applications.
(c) The Executive agrees to cooperate fully with the Company, both during and after his
employment with the Company, with respect to the prosecution, procurement, maintenance and
enforcement and/or defense of patents, trademarks, copyrights, trade secrets and other means for
protection of proprietary information (both in the United States and foreign countries) relating to
Developments. Executive shall sign all papers, including, without limitation, copyright
applications, patent applications, declarations, oaths, formal assignments, assignment of priority
rights, and powers of attorney, which the Company may deem necessary or desirable in order to
protect its rights and interests in any Development. The Executive shall further execute and
deliver all such instruments and take all other actions as in the opinion of the Company and its
counsel shall be appropriate to vest in the Company (or in such person as the Company may specify)
all right, title and interest in said patents, trademarks, copyrights, trade secrets and other
means of protecting proprietary information in any Development.
(d) Whenever requested to do so by the Company, both during and after his employment with the
Company, and at the expense of the Company, the Executive shall cooperate fully and assist in the
Company in the defense or prosecution of any claims or actions now in existence or which may be
brought in the future in connection with (i) any litigation commenced by the Company against third
parties, (ii) any litigation commenced by a third party against the Company and (iii) any
administrative hearing or administrative proceeding involving the Company. The Executive’s full
cooperation in connection with any claims, actions or administrative proceedings shall include, but
not be limited to, his being available to meet with the Company’s counsel to prepare for trial,
discovery or an administrative hearing and to act as a witness when requested by the Company at
reasonable times designated by the Company.
(e) The Executive hereby irrevocably appoints the Company to be his attorney in fact and, in
his name and on his behalf, to execute all such instruments and take all other actions and
generally to use his name for the purpose of providing to the Company the full benefit of the
provisions of this Section 8 of the Agreement.
(f) The Executive hereby waives and quitclaims to the Company any and all claims, of any
nature, which the Executive now or may hereafter have for infringement of any Development assigned
hereunder to the Company.
(g) The Executive acknowledges and agrees that all original works of authorship which are made
by the Executive (solely or jointly with others) within the scope of Executive’s employment and
which are protectable by copyright are “works made for hire,” as that term is defined in the United
States Copyright Act (17 U.S.C. Section 101).
8.3. Other Agreements. Other than as previously disclosed to the Company by the
Executive in writing, the Executive hereby represents that he is not bound by the terms of any
agreement with any previous employer or other party to refrain from using or disclosing any trade
secret or confidential or proprietary information in the course of his employment with the Company
or to refrain from competing, directly or indirectly, with the business of such previous employer
or any other party. The Executive further represents that his performance of all the
- 8 -
terms of this Agreement and as an Executive of the Company does not and will not breach any
agreement to keep in confidence proprietary information, knowledge or data acquired by him in
confidence or in trust prior to his employment with the Company.
9. Other Severance Arrangements. The benefits under this Agreement will be provided
in lieu of benefits under any severance plan of the Company or under the Executive’s offer letter.
The Executive acknowledges and agrees that the acceleration of vesting of stock options and
restricted stock under this Agreement is in lieu of any acceleration of vesting of stock options
and restricted stock upon a change of control under the Company’s current and any future stock
option plans, including but not limited to, the Company’s 2000 Equity Incentive Plan, 2003 Stock
Incentive Plan and 2004 Stock Incentive Plan, each as amended from time to time.
10. Mitigation. The Executive has no obligation to mitigate amounts payable under the
Agreement by seeking other employment.
11. Notices. All notices required or permitted under this Agreement shall be in
writing and shall be deemed effective upon personal delivery or upon deposit in the United States
Post Office, by registered or certified mail, postage prepaid, addressed to the other party at the
address shown above, or at such other address or addresses as either party shall designate to the
other in accordance with this Section 11.
12. Pronouns. Whenever the context may require, any pronouns used in this Agreement
shall include the corresponding masculine, feminine or neuter forms, and the singular forms of
nouns and pronouns shall include the plural, and vice versa.
13. Entire Agreement. This Agreement constitutes the entire agreement between the
parties and supersedes all prior agreements and understandings, whether written or oral, relating
to the subject matter of this Agreement.
14. Amendment. This Agreement may be amended or modified only by a written instrument
executed by both the Company and the Executive.
15. Governing Law. This Agreement shall be construed as a sealed instrument and
interpreted and enforced in accordance with the laws of the Commonwealth of Massachusetts without
regard to conflict of laws provisions. Any action, suit, or other legal proceeding which is
commenced to resolve any matter arising under or relating to any provision of this Agreement shall
be commenced only in a court of the Commonwealth of Massachusetts (or, if appropriate, a federal
court located within the Commonwealth of Massachusetts) and the Company and the Executive each
consents to the jurisdiction of such a court.
16. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of both parties and their respective successors and assigns, including any corporation with
which or into which the Company may be merged or which may succeed to its assets or business,
provided, however, that the obligations of the Executive are personal and shall not be
- 9 -
assigned by the Executive.
17. Legal Fees. The Company will reimburse the Executive for all reasonable legal
fees incurred in enforcing or contesting the Agreement if the Executive prevails on such claim or
claims.
18. Dispute Resolution. Any claim or controversy arising out of or relating to this
Agreement, or any breach thereof, or otherwise arising out of or relating to the Executive’s
employment, compensation and benefits with the Company or the termination thereof including any
claim for discrimination under any local, state or federal employment discrimination law, except as
specifically excluded herein, shall be settled by arbitration in the Commonwealth of Massachusetts,
administered by the American Arbitration Association under its National Rules for the Resolution of
Employment Disputes. Any claim or controversy not submitted to arbitration in accordance with this
Section shall be waived, and thereafter, no arbitration panel or tribunal or court shall have the
power to rule or make any award on any such claim or controversy. The award rendered in any
arbitration proceeding held under this Section 18 shall be final and binding, and judgment upon the
award may be entered in any court having jurisdiction thereof. Claims for workers’ compensation or
unemployment compensation benefits are not covered by this Section. Also not covered by this
Section are claims by the Company or by the Executive for temporary restraining orders or
preliminary injunctions (“temporary equitable relief”) in cases in which such temporary equitable
relief would be otherwise authorized by law, including but not limited to claims for equitable
relief arising out of a breach of Sections 7 and/or 8 of this Agreement. Both the Company and the
Executive expressly waive any right that any party either has or may have to a jury trial of any
dispute arising out of or in any way related to the Executive’s employment with or termination from
the Company. The Executive expressly acknowledges and agrees that he hereby waives any right to
claim or recover punitive damages.
19. Acknowledgment. THE EXECUTIVE STATES THAT HE HAS HAD A REASONABLE PERIOD
SUFFICIENT TO STUDY, UNDERSTAND AND CONSIDER THIS AGREEMENT, THAT HE HAS HAD AN OPPORTUNITY TO
CONSULT WITH LEGAL COUNSEL OF HIS CHOICE, THAT HE HAS READ THIS AGREEMENT AND UNDERSTANDS ALL OF
ITS TERMS, THAT HE IS ENTERING INTO AND SIGNING THIS AGREEMENT KNOWINGLY AND VOLUNTARILY, AND THAT
IN DOING SO HE IS NOT RELYING UPON ANY STATEMENTS OR REPRESENTATIONS BY THE COMPANY OR ITS AGENTS.
20. Miscellaneous.
20.1. No delay or omission by the Company in exercising any right under this Agreement shall
operate as a waiver of that or any other right. A waiver or consent given by the Company on any
one occasion shall be effective only in that instance and shall not be construed as a bar or waiver
of any right on any other occasion.
20.2. The captions of the sections of this Agreement are for convenience of reference only and
in no way define, limit or affect the scope or substance of any section of this
- 10 -
Agreement.
20.3. In case any provision of this Agreement shall be invalid, illegal or otherwise
unenforceable, the validity, legality and enforceability of the remaining provisions shall in no
way be affected or impaired thereby.
20.4. Nothing in this Agreement should be construed to create a trust or to establish or
evidence Executive’s claim of any right to payment other than as an unsecured general creditor with
respect to any payment to which Executive may be entitled.
20.5. The provisions of Sections 7 and 8 shall survive the termination of this Agreement.
20.6. The Executive agrees, upon termination of his employment, promptly to deliver to the
Company all files, books, documents, notes, lab books, memoranda, specifications, cells, storage
media, including software, computer disks or tapes, computer printouts, together will all copies
thereof, and other property prepared by or on behalf of the Company or purchased with Company funds
and to refrain from making, retaining or distributing copies thereof.
21. Definitions.
21.1. For the purposes of this Agreement, “Cause” for termination shall be deemed to exist
upon (a) willful failure by the Executive, which failure is not cured within thirty (30) days of
written notice to the Executive from the Company, to perform his material responsibilities to the
Company; (b) willful misconduct by the Executive that is materially injurious to the Company; (c) a
determination by the Company within thirty (30) days of the Executive’s resignation that discharge
under clause “B” of the definition of Cause was warranted; or (d) a material breach of Section 7 or
8 of this Agreement by the Executive.
21.2. For purposes of this Agreement, a “Change of Control” shall mean:
(a) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3)
or 14(d)(2) of the Exchange Act (as defined below)) (a “Person”) of beneficial ownership of any
capital stock of the Company if, after such acquisition, such Person beneficially owns (within the
meaning of Rule 13d-3 promulgated under the Exchange Act) 50% or more of the combined voting power
of the then-outstanding securities of the Company entitled to vote generally in the election of
directors (the “Outstanding Company Voting Securities”); provided, however, that for
purposes of this subsection (a), the following acquisitions shall not constitute a Change in
Control Event: (A) any acquisition directly from the Company or (B) any acquisition by any
corporation pursuant to a Business Combination (as defined below) which complies with clauses (x)
and (y) of subsection (c) of this definition; or
(b) such time as the Continuing Directors (as defined below) do not constitute a majority of
the Board (or, if applicable, the Board of Directors of a successor corporation to the Company),
where the term “Continuing Director” means at any date a member of the Board (x) who was a member
of the Board on the date of the initial adoption of the Employment
- 11 -
Agreement by the Board or (y) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such nomination or
election or whose election to the Board was recommended or endorsed by at least a majority of the
directors who were Continuing Directors at the time of such nomination or election; provided,
however, that there shall be excluded from this clause (y) any individual whose initial assumption
of office occurred as a result of an actual or threatened election contest with respect to the
election or removal of directors or other actual or threatened solicitation of proxies or consents,
by or on behalf of a person other than the Board; or
(c) the consummation of a merger, consolidation, reorganization, recapitalization or share
exchange involving the Company or a sale or other disposition of all or substantially all of the
assets of the Company (a “Business Combination”), unless, immediately following such Business
Combination, each of the following two conditions is satisfied: (x) all or substantially all of the
individuals and entities who were the beneficial owners of the Outstanding Company Voting
Securities immediately prior to such Business Combination beneficially own, directly or indirectly,
more than 50% of the combined voting power of the then-outstanding securities entitled to vote
generally in the election of directors, respectively, of the resulting or acquiring corporation in
such Business Combination (which shall include, without limitation, a corporation which as a result
of such transaction owns the Company or substantially all of the Company’s assets either directly
or through one or more subsidiaries) (such resulting or acquiring corporation is referred to herein
as the “Acquiring Corporation”) in substantially the same proportions as their ownership of the
Outstanding Company Voting Securities immediately prior to such Business Combination and (y) no
Person (excluding any Executive benefit plan (or related trust) maintained or sponsored by the
Company or by the Acquiring Corporation) beneficially owns, directly or indirectly, 50% or more of
the combined voting power of the then-outstanding securities of such corporation entitled to vote
generally in the election of directors (except to the extent that such ownership existed prior to
the Business Combination); or
(d) the liquidation or dissolution of the Company.
21.3. For purposes of this Agreement, a “Change of Control Period” shall consist of the period
from three (3) months before until one (1) year after the date on which a Change of Control occurs.
21.4. As used in this Agreement, the term “disability” shall mean total and permanent
disability or the inability of the Executive to perform the services contemplated under this
Agreement with reasonable accommodation as may be required by State or Federal law, due to a
physical or mental disability, for a period of one hundred and eighty (180) days, whether or not
consecutive, during any 360-day period. A determination of disability shall be agreed upon by a
physician satisfactory to the Executive and a physician selected by the Company, provided
that if these physicians do not agree, the Executive and the Company shall each select a
physician and these two together shall select a third physician, whose determination as to
disability shall be binding on all parties.
- 12 -
21.5. As used in this Agreement, the term “Exchange Act” shall mean the Securities Exchange
Act of 1934, as amended.
21.6. For purposes of this Agreement, “Good Reason” shall be deemed to exist upon (a) any
reduction in the annual base compensation payable to the Executive (but exclusive of any Target
Cash Bonus, annual equity award or other similar cash bonus or equity plans for this purpose); (b)
the relocation of the place of business at which the Executive is principally located to a location
that is greater than thirty (30) miles from its current location; (c) the failure of the Company to
comply with a material term of this Agreement; or (d) significant reduction in the Executive’s
duties, responsibilities or position.
21.7. For purposes of this Agreement, “pro rata payment” shall be deemed to mean the
calculation of a payment by the Company based on the proportion of the calendar year completed,
based on the nearest whole number of months of Executive’s employment (for illustrative purposes
only, if Executive was terminated without Cause by the Company on April 13th of a given
year, Executive would be entitled to 1/4 of his Target Cash Bonus for such year under Section
5.4(iii)).
22. Non-Disparagement. The Executive understands and agrees that as a condition to
him of the monetary consideration provided in connection with this Agreement, during the term of
the Agreement and for a period of two (2) years after the termination of his employment with the
Company for any reason, he shall not make any false, disparaging or derogatory statements in public
or private to any person or media outlet regarding the Company or any of its directors, officers,
employees, agents, or representatives or the Company’s business affairs and financial condition.
23. Section 409A.
23.1 Neither the Executive nor the Company shall have the right to accelerate or defer the
delivery of the payments to be made pursuant to this Agreement. If the payments to be made under
this Agreement are determined to be “nonqualified deferred compensation” within the meaning of
Section 409A of the Internal Revenue Code of 1986, as amended and the guidance issued thereunder
(“Section 409A”), and the Executive is a “specified employee” within the meaning of Section 409A,
then the delivery of any payments to be made hereunder will be delayed to the date that is six
months following the Executive’s termination date.
23.2 This Agreement is intended to comply with the provisions of Section 409A and shall be
construed consistently therewith.
[Remainder of this page is intentionally left blank]
- 13 -
SIGNATURE PAGE TO EMPLOYMENT AGREEMENT
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year set
forth above.
| CRITICAL THERAPEUTICS, INC. | ||||||
| By: | /s/ XXXXX X. XXXXXX | |||||
| Name: Xxxxx X. Xxxxxx Title: President |
||||||
| EXECUTIVE | ||||||
| /s/ XXXXXXX X. XXXXX | ||||||
| Xxxxxxx X. Xxxxx | ||||||
- 14 -
